FIELD TOLERANCE OF SELECTED VARIETIES TO AND FUNGICIDE EFFICACY AGAINST ALTERNARIA BLIGHT OF SWEET POTATO

Alternaria blight (AB) of sweet potato ( Ipomoea batatas L. ), caused by Alternaria spp., was recently reported in South Africa, but is common in southern and eastern Africa. Elsewhere in the world, AB is controlled primarily using resistant varieties. Twenty-five sweet potato varieties/breeding lines, from different origins were assessed for tolerance to AB. The materials were planted in fields having a history of AB disease and rated for tolerance based on a General Disease Index (GDI), with the lowest scores representing tolerance, and the higher scores representing susceptibility. Variety 199062-1 had the lowest GDI value, and was the most tolerant to AB; while W119 had the highest GDI value and was the most susceptible to the disease. Other varieties/breeding lines showed a variation in GDI values between most tolerant and most susceptible. Among the fungicides tested under field conditions, the mixture azoxystrobin-difenoconazole was the most effective in reducing AB intensity. Fungicides pyraclostrobin-boscalid, unizeb, azoxystrobin-chlorothalonil and cymoxanil-mancozeb were also effective against the disease.

Comparison of Complications and Efficacy of NIPPV and Nasal CPAP in Preterm Infants With RDS

Background: Respiratory distress syndrome (RDS) is one of the most common diseases in neonates admitted to NICU. For this important cause of morbidity and mortality in preterm neonates, several treatment methods have been used. To date, non-invasive methods are preferred due to fewer complications. Objectives: Herein, two non-invasive methods of ventilation support are compared: NCPAP vs. NIPPV. Patients and Methods: This is a randomized clinical trial. Premature neonates with less than 34 weeks gestation, suffering from RDS entered the study, including 151 newborns admitted to Vali-Asr NICU during 2012-2013. Most of these patients received surfactant as early rescue via INSURE method and then randomly divided into two NCPAP (73 neonates) and NIPPV (78 neonates) groups. Both early and late complications are compared including extubation failure, hospital length of stay, GI perforation, apnea, intraventricular hemorrhage (IVH) and mortality rate. Results: The need for re-intubation was 6% in NIPPV vs. 17.6% in NCPAP group, which was statistically significant (P = 0.031). The length of hospital stay was 23.92 ± 13.5 vs. 32.61 ± 21.07 days in NIPPV and NCPAP groups, respectively (P = 0.002). Chronic lung disease (CLD) was reported to be 4% in NCPAP and 0% in NIPPV groups (P = 0.035). The most common complication occurred in both groups was traumatization of nasal skin and mucosa, all of which fully recovered. Gastrointestinal perforation was not reported in either group. Conclusions: This study reveals the hospital length of stay, re-intubation and BPD rates are significantly declined in neonates receiving NIPPV as the treatment for RDS.